Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > It Was Just A Typo

<< Previous

Bullboard Posts

Next >>

Comment by itntdfon Jun 27, 2024 4:44pm

87 Views

Post# 36109681

RE:RE:RE:RE:RE:RE:RE:RE:It Was Just A Typo

you seem to have a basic misunderstanding about a service agent and what a service agent's responsibilities are.

they accept service of documents on behalf of a company. they do NOT write the documents. suggest you google what a service agent is before you fall off don's horse and hurt yourself.

<< Previous

Bullboard Posts

Next >>

Osisko Development receives permits for Cariboo Gold Project